Detalles de la búsqueda
1.
The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous Transplantation.
Oncologist
; 2024 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38339976
2.
Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study.
Ann Hematol
; 103(3): 803-811, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37950052
3.
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity.
Ann Hematol
; 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38695872
4.
Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-Cell Lymphoma, Leg-Type: A Case Report.
Chemotherapy
; 69(1): 23-26, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37913761
5.
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia.
Hematol Oncol
; 40(1): 57-62, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34653277
6.
Hepatosplenic T-Cell Non-Hodgkin Lymphoma Cured with Tandem Autologous and Allogeneic Stem Cell Transplantation.
Chemotherapy
; 67(4): 253-255, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35537403
7.
Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients.
Ann Hematol
; 100(9): 2261-2268, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33305333
8.
The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience.
Am J Hematol
; 96(10): 1204-1210, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34245477
9.
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study.
Haematologica
; 105(6): 1604-1612, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31537689
10.
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients.
Hematol Oncol
; 38(4): 487-492, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32594531
11.
Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real-life experience.
Hematol Oncol
; 38(5): 737-741, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32905626
12.
Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial.
Eur J Nucl Med Mol Imaging
; 46(8): 1661-1671, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31102000
13.
A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies.
Hematol Oncol
; 37(2): 202-204, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30637815
14.
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).
Oncologist
; 23(9): 1033-1038, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29674440
15.
A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report.
BMC Cancer
; 18(1): 645, 2018 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29879938
16.
Efficacy and safety of biosimilar epoetin alpha in patients with chronic lymphoid neoplasms and chemotherapy-induced anaemia: An observational, retrospective, monocentric analysis.
Hematol Oncol
; 36(1): 136-143, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28332724
17.
Two cases of primary vitreoretinal lymphoma: a diagnostic challenge : The supporting role of multimodal imaging in the diagnosis of primary vitreoretinal lymphoma.
Int Ophthalmol
; 38(1): 353-361, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28039672
18.
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.
Haematologica
; 102(11): 1931-1935, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28775121
19.
The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients.
BMC Cancer
; 17(1): 276, 2017 04 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-28415982
20.
Brentuximab vedotin in the treatment of relapsed/refractory CD30+ peripheral T-cell lymphoma: A FIL phase 2 study.
Hematol Oncol
; 40(2): 307-309, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35023190